ADIL
Adial Pharmaceuticals · USD
Deep AI analysis (big model)
BUY · 75%The stock ADIL has shown a strong bullish trend over the past few days, with its price rising by +53.5% and closing at $2.21 on June 5th. The technical analysis indicates a bullish signal, supported by an RSI value of 64.42, which suggests that the stock is not oversold. Additionally, the MACD bullish crossover and the fact that the 50-day moving average (SMA) is above the 200-day SMA indicate potential upward momentum. Although there are no recent news findings to influence sentiment positively or negatively, the price action and technical indicators suggest a favorable environment for long-term investors. However, it's important to monitor the stock closely given its significant volatility.
About Adial Pharmaceuticals
Adial Pharmaceuticals (ADIL) is a pharmaceutical company focused on developing and commercializing drugs for the treatment of sleep disorders, primarily using its proprietary DMT-101 drug delivery system.
| Ticker | ADIL |
| Name | Adial Pharmaceuticals |
| Currency | USD |
| Sector | Healthcare |
Reputation
Reputation builds as news about this company is analysed.
Price history & forecast
30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.
Candlestick, volume & news sentiment
Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.
Forecast accuracy (backtested)
No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).
Technical analysis
BEARISHComputed from 256 locally-stored price bars.
AI signals
-
HOLD 70% · long_term 2026-06-08 10:13
The stock has experienced a significant upward move over the past week, with recent closes around or below the initial close of 2.21 USD. The lack of new positive news in recent days suggests that the current momentum might be waning and could potentially reverse if no further catalysts are provided. This setup leans more towards a bearish outlook as it indicates a possible consolidation phase.
qwen2.5:3b
Related news
- No matched headlines yet.